These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 16795934)

  • 41. Reuse of single-use medical devices: informed consent and physician liability.
    Colonna TE; Thomas DE
    Tex Med; 1999 Mar; 95(3):64-7. PubMed ID: 10932637
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Medical devices; patient examination and surgeons' gloves; test procedures and acceptance criteria. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2006 Dec; 71(243):75865-79. PubMed ID: 17294550
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Medical devices: the obvious, the readily-accepted, and the surprising.
    Tolomeo DE; Clarke LA
    J Health Life Sci Law; 2008 Jul; 1(4):117, 119-44. PubMed ID: 18717154
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Medical devices: cardiovascular devices: reclassification of the arrhythmia detector and alarm. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Oct; 68(208):61342-4. PubMed ID: 14584507
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardiovascular and neurological devices; reclassification of two embolization devices. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Dec; 69(249):77898-900. PubMed ID: 15624254
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dental devices; dental noble metal alloys and dental base metal alloys; designation of special controls. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Aug; 69(162):51765-6. PubMed ID: 15329980
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Foreign establishment registration and listing. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Nov; 66(228):59138-61. PubMed ID: 11776289
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Home health care nursing: liability and risk management for "informed consent" and "The Safe Medical Devices Act" duties.
    Blumenthal JB; Hayes EJ
    J Health Hosp Law; 1995; 28(5):286-91, 309. PubMed ID: 10156294
    [No Abstract]   [Full Text] [Related]  

  • 49. Access to clinical devices through nontraditional routes.
    Klepinski RJ
    Food Drug Law J; 2007; 62(4):849-63. PubMed ID: 18557233
    [No Abstract]   [Full Text] [Related]  

  • 50. Medical Devices; hematology and pathology devices; reclassification of automated blood cell separator device operating by filtration principle from class III to class II. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Feb; 68(40):9530-2. PubMed ID: 12617085
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An overview of FDA medical device regulation as it relates to deep brain stimulation devices.
    Peña C; Bowsher K; Costello A; De Luca R; Doll S; Li K; Schroeder M; Stevens T
    IEEE Trans Neural Syst Rehabil Eng; 2007 Sep; 15(3):421-4. PubMed ID: 17894274
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effective date of requirement for premarket approval for a pacemaker programmer. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2012 Jun; 77(121):37570-3. PubMed ID: 22730574
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Procedures for emergency or treatment use of investigational drugs.
    Klecker RJ; Cipolle RJ
    Am J Hosp Pharm; 1987 May; 44(5):1086-9. PubMed ID: 3605118
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Food and Drug Administration's perspectives on pediatric cardiac assist devices.
    Chen EA; Patel-Raman SM; Berman MR; Zuckerman BD
    ASAIO J; 2008; 54(2):147-9. PubMed ID: 18356646
    [TBL] [Abstract][Full Text] [Related]  

  • 55. U.S. Federal Regulations for emergency research: a practical guide and commentary.
    McRae A; Weijer C
    Acad Emerg Med; 2008 Jan; 15(1):88-97. PubMed ID: 18211320
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Medical devices; general and plastic surgery devices; classification of the low energy ultrasound wound cleaner. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2005 Nov; 70(214):67353-5. PubMed ID: 16273747
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human cells, tissues, and cellular and tissue-based products; donor screening and testing, and related labeling. Interim final rule; opportunity for public comment.
    Food and Drug Administration, HHS
    Fed Regist; 2005 May; 70(100):29949-52. PubMed ID: 15915582
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Food and Drug Administration and pragmatic clinical trials of marketed medical products.
    Anderson ML; Griffin J; Goldkind SF; Zeitler EP; Wing L; Al-Khatib SM; Sherman RE
    Clin Trials; 2015 Oct; 12(5):511-9. PubMed ID: 26374684
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Implementing the Food and Drug Administration's final rule for waiver of informed consent in certain emergency research circumstances.
    Biros MH; Fish SS; Lewis RJ
    Acad Emerg Med; 1999 Dec; 6(12):1272-82. PubMed ID: 10609930
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ethical and regulatory challenges associated with the exception from informed consent requirements for emergency research: from experimental design to institutional review board approval.
    Vaslef SN; Cairns CB; Falletta JM
    Arch Surg; 2006 Oct; 141(10):1019-23; discussion 1024. PubMed ID: 17043281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.